Haemonetics (HAE) International Revenue Performance Explored

Core Viewpoint - The performance of Haemonetics' international operations is crucial for assessing its financial resilience and growth prospects, especially in the context of a highly interconnected global economy [2][3]. Group 1: Financial Performance Overview - For the quarter ended December 2025, Haemonetics reported total revenue of $338.97 million, reflecting a decline of 2.8% year over year [4]. - The company is projected to achieve total revenue of $1.32 billion for the full year, indicating a fall of 2.6% from the previous year [9]. Group 2: International Revenue Breakdown - Japan contributed $18.14 million, or 5.4% of total revenue, with a surprise increase of +1.87% compared to analyst expectations [5]. - Europe generated $48.28 million, accounting for 14.2% of total revenue, surpassing projections by +6.65% [6]. - Other International regions contributed $1.81 million, making up 0.5% of total revenue, which was a decline of -22.23% from expectations [7]. Group 3: Future Revenue Expectations - Analysts anticipate revenues of $336.54 million for the current fiscal quarter, representing an increase of 1.8% year over year [8]. - Expected revenue contributions for the current quarter are projected to be 5.6% from Japan ($18.94 million), 13.5% from Europe ($45.38 million), and 1.2% from Other International ($3.93 million) [8].